{"schema_version":"secwatch.filing_event.v1","accession":"0000081362-25-000056","form_type":"8-K","ticker":"KWR","cik":"0000081362","company_name":"QUAKER CHEMICAL CORP","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.366995+00:00","generated_at":"2026-05-23T01:31:48.584332+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quaker Houghton Q1 revenue down 6% to $442.9M; non-GAAP EPS $1.58 vs $2.09; 2025 outlook in-line with 2024","bullets":["Net sales $442.9M, down 6% YoY; net income $12.9M ($0.73 diluted) vs $35.2M ($1.95) in Q1 2024.","Non-GAAP net income $28.0M, or $1.58 per diluted share, vs $37.7M ($2.09) prior year.","Adjusted EBITDA $69.0M (15.6% margin) vs $83.3M in Q1 2024, down 17% on lower volumes.","Acquired Dipsol Chemicals ($155.2M), Natech ($6.5M), and CSI ($3.9M) to strengthen portfolio.","Guidance: expects 2025 revenue and earnings in-line with 2024; soft end markets persist into H2."],"urls":{"canonical":"https://secwatch.observer/filing/0000081362-25-000056","json":"https://secwatch.observer/filing/0000081362-25-000056.json","markdown":"https://secwatch.observer/filing/0000081362-25-000056.md","text":"https://secwatch.observer/filing/0000081362-25-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/81362/000008136225000056/0000081362-25-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/81362/000008136225000056/kwr-20250501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:31:48.584332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}